1. Home
  2. PMCB vs ROMA Comparison

PMCB vs ROMA Comparison

Compare PMCB & ROMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • ROMA
  • Stock Information
  • Founded
  • PMCB 1996
  • ROMA 2018
  • Country
  • PMCB United States
  • ROMA Hong Kong
  • Employees
  • PMCB N/A
  • ROMA N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • ROMA Savings Institutions
  • Sector
  • PMCB Health Care
  • ROMA Finance
  • Exchange
  • PMCB Nasdaq
  • ROMA Nasdaq
  • Market Cap
  • PMCB 11.4M
  • ROMA 10.5M
  • IPO Year
  • PMCB N/A
  • ROMA 2024
  • Fundamental
  • Price
  • PMCB $1.76
  • ROMA $0.73
  • Analyst Decision
  • PMCB
  • ROMA
  • Analyst Count
  • PMCB 0
  • ROMA 0
  • Target Price
  • PMCB N/A
  • ROMA N/A
  • AVG Volume (30 Days)
  • PMCB 27.2K
  • ROMA 42.4K
  • Earning Date
  • PMCB 03-17-2025
  • ROMA 12-16-2024
  • Dividend Yield
  • PMCB N/A
  • ROMA N/A
  • EPS Growth
  • PMCB N/A
  • ROMA N/A
  • EPS
  • PMCB 0.74
  • ROMA N/A
  • Revenue
  • PMCB N/A
  • ROMA $1,029,120.00
  • Revenue This Year
  • PMCB N/A
  • ROMA N/A
  • Revenue Next Year
  • PMCB N/A
  • ROMA N/A
  • P/E Ratio
  • PMCB $2.37
  • ROMA N/A
  • Revenue Growth
  • PMCB N/A
  • ROMA N/A
  • 52 Week Low
  • PMCB $1.39
  • ROMA $0.40
  • 52 Week High
  • PMCB $2.58
  • ROMA $1.85
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 60.08
  • ROMA 55.32
  • Support Level
  • PMCB $1.57
  • ROMA $0.58
  • Resistance Level
  • PMCB $1.66
  • ROMA $0.71
  • Average True Range (ATR)
  • PMCB 0.12
  • ROMA 0.07
  • MACD
  • PMCB 0.02
  • ROMA 0.01
  • Stochastic Oscillator
  • PMCB 68.89
  • ROMA 88.24

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About ROMA Roma Green Finance Limited

Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage and overcome various business matters arising from such factors related to ESG, sustainability and climate change. it provides tailored-made sustainability solutions to meet the client's specific needs. Its mission is to provide its clients with a one-stop destination for high-quality and holistic sustainability and climate change-related consulting services to support a more sustainable, balanced and inclusive future for its clients' organizations and the world.

Share on Social Networks: